Woman petitions health insurer after company approves — then rejects — her infusions

FHS
January 4, 2024
10:52 am

When KFF Health News published an article in August about the “prior authorization hell” Sally Nix said she went through to secure approval from her insurance company for the expensive monthly infusions she needs, we thought her story had a happy ending.

Native American public health officials are stuck in data blind spot

It’s not easy to make public health decisions without access to good data. And epidemiologists and public health workers for Native American communities say they’re

August 6, 2024

Biotest increases sales in the first half of 2024 by 35% to Euro 372 million – Biotech Investments

EQS-News: Biotest AG / Key word(s): Half Year Report Biotest increases sales in the first half of 2024 by 35% to Euro 372 million 06.08.2024

August 7, 2024

Pharmalittle: FDA grants full approval to Alzheimer’s drug; Sanders blocks NIH nominee over drug costs

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.